Background/Objectives: We compared the visibility of breast cancer using the newly developed standing automated breast ultrasound system (MammouS-N) and digital breast tomosynthesis (DBT), and identified factors influencing lesion visibility. Methods: We prospectively enrolled 100 women (mean age: 51.6 years; range: 26–76 years) who were diagnosed with breast cancer and were scheduled to undergo DBT between January and July 2024. They underwent DBT and an ultrasound on the same day. Two radiologists evaluated the visibility scores (0–5) of lesions corresponding to biopsy-confirmed breast cancers identified using magnetic resonance imaging. The Wilcoxon signed-rank test was used to compare the visibility scores of cancers identified on DBT and/or MammouS-N images. Results: Among the 100 women, invasive ductal carcinoma was the most common malignancy (73%). DBT findings included negative findings (7%), masses (46%), masses with calcification (29%), calcifications only (15%), and architectural distortions (3%). On MammouS-N ultrasound, most lesions were classified as masses (93%), whereas 7% were non-mass lesions. For Reviewer 1, MammouS-N demonstrated significantly higher visibility scores (higher scores: 26 on MammouS-N, seven on DBT; equal scores: 67, z = −3.234, p = 0.001). For Reviewer 2, the two modalities showed no significant difference in visibility (higher scores: 27 on MammouS-N, 28 on DBT, equal scores: 45, z = −0.040, p = 0.968). Noncalcified lesions that were obscured on DBT were better visualized on MammouS-N (p < 0.001) by both reviewers. Conclusions: MammouS-N holds promise as an imaging modality complementary to DBT in women with dense breast tissue, particularly for non-calcified lesion detection.
Background/Objectives: To identify preoperative MRI features using computer-assisted diagnosis (CAD) that are associated with invasive disease-free survival (IDFS) and distant metastasis-free survival (DDFS) in patients with primarily operable triple-negative breast cancer (TNBC). Methods: This retrospective study was approved by the institutional review board with informed consent was waived. Between January 2012 and December 2014, 74 consecutive women with primary TNBC (mean age, 51 years; range, 29–77 years) who underwent preoperative MRI were included and followed until August 2021. Dynamic contrast-enhanced and T2-weighted images were obtained using 3T scanners. Peritumoral edema and central necrosis were evaluated retrospectively. CAD was used to extract 3D diameters, angiovolume, and kinetic parameters, and kinetic heterogeneity was calculated. Cox proportional hazards models were used to assess associations between MRI features and IDFS and DDFS, adjusting for clinicopathologic factors. Results: During a median follow-up of 80.9 months, 12 patients developed invasive disease, and 8 developed distant metastasis. In multivariable analysis, peak enhancement (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.06–1.84; p = 0.019) and angiovolume (HR, 2.86; 95% CI, 1.26–6.47; p = 0.012) were independently associated with IDFS, whereas angiovolume (HR, 2.47; 95% CI: 1.28–4.78; p = 0.007) was independently associated with DDFS. Conclusions: Preoperative CAD-derived MRI features, particularly peak enhancement and angiovolume, were associated with IDFS in TNBC patients whereas angiovolume alone was associated with DDFS.